SCHOLAR ROCK HOLDING CORPORATION Public Float
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Public Float of $2.60 billion as of 2025-06-30, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-03
- 2025-06-30: Entity Public Float $2.60B.
- 2024-06-30: Entity Public Float $394.70M.
- 2023-06-30: Entity Public Float $158.30M.
- 2022-06-30: Entity Public Float $109.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.60B 10-K · filed 2026-03-03 |
| 2024-06-30 | $394.70M 10-K · filed 2025-02-27 |
| 2023-06-30 | $158.30M 10-K · filed 2024-03-19 |
| 2022-06-30 | $109.50M 10-K · filed 2023-03-07 |
| 2021-06-30 | $531.80M 10-K · filed 2022-03-07 |
| 2020-06-30 | $339.80M 10-K · filed 2021-03-09 |
| 2019-06-28 | $185.10M 10-K · filed 2020-03-12 |
| 2018-06-29 | $127.20M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |